Gastric leiomyoblastoma in childhood.

J Pediatr Surg

First Department of Surgery, Tottori University School of Medicine, Yonago, Japan.

Published: February 1991

A case of gastric leiomyoblastoma in a 7-year-old girl, who underwent partial gastrectomy combined with complete removal of perigastric lymph nodes, is reported. Characteristics of the behavior and prognosis of gastric leiomyoblastomas in childhood are discussed in a review of the world literature.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0022-3468(91)90919-kDOI Listing

Publication Analysis

Top Keywords

gastric leiomyoblastoma
8
leiomyoblastoma childhood
4
childhood case
4
case gastric
4
leiomyoblastoma 7-year-old
4
7-year-old girl
4
girl underwent
4
underwent partial
4
partial gastrectomy
4
gastrectomy combined
4

Similar Publications

Article Synopsis
  • Gastrointestinal stromal tumors (GISTs) are the most common type of mesenchymal tumors in the gastrointestinal tract, often found in the stomach and can present with vague symptoms or be discovered accidentally during unrelated investigations.
  • The diagnosis of GISTs relies on identifying specific cell types through cytology and immunohistochemical markers like CD117, as well as recognizing mutations in genes such as KIT and PDGFRA that guide treatment with tyrosine kinase inhibitors.
  • Differentiating GISTs from other similar tumors like leiomyoma and schwannoma is essential; the grading based on mitotic rates helps in predicting the outcome, and the article provides a case study illustrating these diagnostic techniques.
View Article and Find Full Text PDF

Background: The diagnosis of spindle cell neoplasms (SCN) of the upper gastrointestinal (GI) tract, hepatobiliary tract, and pancreas detected by fine needle aspiration (FNA) is challenging. We describe a single-center experience of these samples with follow-up data and characterization of the morphologic findings.

Methods: We retrospectively reviewed pathology records for all FNAs diagnostic for or suggestive of SCN on esophagus, stomach, small bowel, liver, and pancreas in a 15 year period.

View Article and Find Full Text PDF
Article Synopsis
  • PDGFRA is a receptor tyrosine kinase involved in gastrointestinal stromal tumors (GISTs) and is mutated in 10% of GISTs and 55%-70% of inflammatory fibroid polyps, primarily affecting stomach tumors.
  • Avapritinib has been approved for treating PDGFRA D842V-mutant GISTs, which typically don't respond to standard therapies.
  • Immunohistochemistry (IHC) for PDGFRA shows high sensitivity (100%) and moderate specificity (around 81%) for identifying PDGFRA-mutant GISTs, assisting in directing targeted therapies effectively.
View Article and Find Full Text PDF
Article Synopsis
  • Gastrointestinal stromal tumors (GISTs) are controversial among pathologists regarding their origin, classification, and potential for malignancy.
  • Prior to 1998, GISTs were often misclassified as other types of mesenchymal tumors due to a lack of understanding until KIT gene mutations were identified.
  • When a GIST is detected, imaging tests like ultrasounds and CT scans help determine the size and location of the tumor, typically found in the stomach or intestines, allowing the medical team to narrow down the diagnosis.
View Article and Find Full Text PDF

Background: Although gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract, they comprise less than 1% of all gastrointestinal tumors. Neuroendocrine tumors (NET) of the gastro-enteropancreatic system are also rare, representing about 2% of all gastrointestinal neoplasms. Pancreatic localization of NET is extremely uncommon-these tumors are only 1-5% of all pancreatic cancers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!